Drug information for TALACEN
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET; ORAL
650MG;EQ 25MG BASE
Discontinued
ACETAMINOPHEN
;
PENTAZOCINE HYDROCHLORIDE
Pentazocine
SANOFI AVENTIS US
18458
2011-06-29 Label
2011-06-28 Letter
2011-03-08 Letter
2011-03-07 Label
2008-08-12 Letter
2003-07-28 Letter
Drug Adverse Effects information for TALACEN
Role code
Indications
Reaction
# Reports
C
ANTICOAGULANT THERAPY
DEPRESSION
1
C
ANTICOAGULANT THERAPY
PULMONARY EMBOLISM
1
C
HEADACHE
DEPRESSION
1
C
HEADACHE
PULMONARY EMBOLISM
1
C
MIGRAINE
DEPRESSION
1
C
MIGRAINE
PULMONARY EMBOLISM
1
C
OSTEOPOROSIS
ACTINIC KERATOSIS
2
C
OSTEOPOROSIS
ANAEMIA OF CHRONIC DISEASE
2
C
OSTEOPOROSIS
ANGIOPATHY
2
C
OSTEOPOROSIS
ANTIBIOTIC RESISTANT STAPHYLOCOCCUS TEST POSITIVE
2
C
OSTEOPOROSIS
ARTHROPATHY
2
C
OSTEOPOROSIS
ARTHROPOD BITE
2
C
OSTEOPOROSIS
BASAL CELL CARCINOMA
2
C
OSTEOPOROSIS
BONE LOSS
2
C
OSTEOPOROSIS
BRONCHITIS
2
C
OSTEOPOROSIS
BUNION
2
C
OSTEOPOROSIS
CARDIAC MURMUR
2
C
OSTEOPOROSIS
CARPAL TUNNEL SYNDROME
2
C
OSTEOPOROSIS
CELLULITIS
2
C
OSTEOPOROSIS
CONTUSION
2
C
OSTEOPOROSIS
CUTANEOUS LUPUS ERYTHEMATOSUS
2
C
OSTEOPOROSIS
DECUBITUS ULCER
2
C
OSTEOPOROSIS
DEHYDRATION
2
C
OSTEOPOROSIS
DENTAL FISTULA
2
C
OSTEOPOROSIS
DRY SKIN
2
C
OSTEOPOROSIS
EXCORIATION
2
C
OSTEOPOROSIS
EYE DISORDER
2
C
OSTEOPOROSIS
FAILURE TO THRIVE
2
C
OSTEOPOROSIS
FALL
2
C
OSTEOPOROSIS
FISTULA DISCHARGE
2
C
OSTEOPOROSIS
GINGIVAL BLEEDING
2
C
OSTEOPOROSIS
GINGIVAL DISORDER
2
C
OSTEOPOROSIS
GINGIVAL PAIN
2
C
OSTEOPOROSIS
GINGIVAL RECESSION
2
C
OSTEOPOROSIS
GINGIVITIS
2
C
OSTEOPOROSIS
GLAUCOMA
2
C
OSTEOPOROSIS
IMPAIRED HEALING
2
C
OSTEOPOROSIS
INCREASED TENDENCY TO BRUISE
2
C
OSTEOPOROSIS
INTERVERTEBRAL DISC DEGENERATION
2
C
OSTEOPOROSIS
LIP ULCERATION
2
C
OSTEOPOROSIS
LOOSE TOOTH
2
C
OSTEOPOROSIS
MELANOCYTIC NAEVUS
2
C
OSTEOPOROSIS
MITRAL VALVE PROLAPSE
2
C
OSTEOPOROSIS
MULTI-ORGAN FAILURE
2
C
OSTEOPOROSIS
MYELODYSPLASTIC SYNDROME
2
C
OSTEOPOROSIS
OEDEMA MOUTH
2
C
OSTEOPOROSIS
OEDEMA PERIPHERAL
2
C
OSTEOPOROSIS
ORAL DISORDER
2
C
OSTEOPOROSIS
ORAL INFECTION
2
C
OSTEOPOROSIS
OSTEOMYELITIS
2
C
OSTEOPOROSIS
OSTEONECROSIS OF JAW
2
C
OSTEOPOROSIS
PATHOLOGICAL FRACTURE
2
C
OSTEOPOROSIS
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
2
C
OSTEOPOROSIS
PERIPHERAL VASCULAR DISORDER
2
C
OSTEOPOROSIS
PHOTODERMATOSIS
2
C
OSTEOPOROSIS
PNEUMONIA
2
C
OSTEOPOROSIS
POOR PERSONAL HYGIENE
2
C
OSTEOPOROSIS
PSORIASIS
2
C
OSTEOPOROSIS
RASH
2
C
OSTEOPOROSIS
RENAL FAILURE ACUTE
2
C
OSTEOPOROSIS
RENAL FAILURE CHRONIC
2
C
OSTEOPOROSIS
SEBORRHOEIC KERATOSIS
2
C
OSTEOPOROSIS
SKIN ULCER
2
C
OSTEOPOROSIS
SQUAMOUS CELL CARCINOMA OF SKIN
2
C
OSTEOPOROSIS
TOOTH DISORDER
2
C
OSTEOPOROSIS
TREATMENT NONCOMPLIANCE
2
C
OSTEOPOROSIS
WEIGHT DECREASED
2
C
PREMENSTRUAL SYNDROME
DEPRESSION
2
C
PREMENSTRUAL SYNDROME
PULMONARY EMBOLISM
2
C
SCHIZOAFFECTIVE DISORDER
AGGRESSION
2
C
SCHIZOAFFECTIVE DISORDER
HOSPITALISATION
1
Ads by Google